Phaos Technology Holdings (Cayman) (POAS) Receivables - Other (2024 - 2025)
Phaos Technology Holdings (Cayman)'s (POAS) quarterly Receivables - Other came in at $2.9 million in Q4 2025, up 28.79% on a QoQ basis from $2.2 million in Q2 2025.
Phaos Technology Holdings (Cayman) (POAS) Receivables - Other (2024 - 2025) Analysis & Trends
Phaos Technology Holdings (Cayman) (POAS) has 2 years of Receivables - Other data on file, last reported at $2.9 million in Q4 2025.
- Quarterly Receivables - Other changed N/A year-over-year to $2.9 million in Q4 2025, while the trailing twelve-month figure through Oct 2025 was $2.9 million (changed N/A YoY) and the FY2025 annual result came in at $2.3 million, up 321.74% from the prior year.
- Receivables - Other improved to $2.9 million in Q4 2025, from $2.2 million in the prior quarter.
- In the past five years, Receivables - Other ranged from a high of $2.9 million in Q4 2025 to a low of $544056.1 in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.51 Bn | 194.91 Bn | 7.27 Bn |
| 2 | Stryker | 129.96 Bn | 126.48 Bn | 4.50 Bn |
| 3 | Medtronic | 120.18 Bn | 110.96 Bn | 6.41 Bn |
| 4 | Boston Scientific | 74.28 Bn | 73.74 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 52.75 Bn | 48.50 Bn | 1.35 Bn |
| 6 | Dexcom | 34.67 Bn | 32.73 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 34.23 Bn | 32.12 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.46 Bn | 23.14 Bn | 4.55 Bn |
| 9 | Steris | 23.30 Bn | 22.82 Bn | 684.20 Mn |
| 10 | Phaos Technology Holdings (Cayman) | 4.12 Mn | 4.08 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Oct 31, 2025 | 2.89 Mn |
| Oct 31, 2025 | 2.89 Mn |
| Apr 30, 2025 | 2.24 Mn |
| Apr 30, 2025 | 2.24 Mn |
| Apr 30, 2024 | 544,056.13 |
| Apr 30, 2024 | 544,056.13 |